<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35524358</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1539-6304</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Allergy and asthma proceedings</Title><ISOAbbreviation>Allergy Asthma Proc</ISOAbbreviation></Journal><ArticleTitle>Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome.</ArticleTitle><Pagination><StartPage>187</StartPage><EndPage>193</EndPage><MedlinePgn>187-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2500/aap.2022.43.220018</ELocationID><Abstract><AbstractText><b>Background:</b> Long COVID (coronavirus disease 2019) syndrome includes a group of patients who, after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibit lingering mild-to-moderate symptoms and develop medical complications that can have lasting health problems. In this report, we propose a model for the pathophysiology of the long COVID presentation based on increased proinflammatory cytokine production that results from the persistence of the SARS-CoV-2 virus or one of its molecular components. Associated with this hyperproduction of inflammatory cytokines is a heightened activity of nuclear factor &#x3ba; B (NF-&#x3ba;B) and p38 mitogen-activated protein kinase signaling pathways that regulate cytokine production. <b>Objective:</b> The purpose of the present report was to review the causes of long COVID syndrome and suggest ways that can provide a basis for a better understanding of the clinical symptomatology for the of improved diagnostic and therapeutic procedures for the condition. <b>Methods:</b> Extensive research was conducted in medical literature data bases by applying terms such as "long COVID" associated with "persistence of the SARS-CoV-2 virus" "spike protein' "COVID-19" and "biologic therapies." <b>Results and Conclusions:</b> In this model of the long COVID syndrome, the persistence of SARS-CoV-2 is hypothesized to trigger a dysregulated immune system with subsequent heightened release of proinflammatory cytokines that lead to chronic low-grade inflammation and multiorgan symptomatology. The condition seems to have a genetic basis, which predisposes individuals to have a diminished immunologic capacity to completely clear the virus, with residual parts of the virus persisting. This persistence of virus and resultant hyperproduction of proinflammatory cytokines are proposed to form the basis of the syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli Istituti di Ricovero e Cura a Carattere Scientifico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazza</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Section, Department of Surgery, Dentistry, Paediatrics, and Gynaecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boner</LastName><ForeName>Attilio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Pediatric Section, Department of Surgery, Dentistry, Paediatrics, and Gynaecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellanti</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Georgetown University Medical Center, Washington D.C.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Allergy Asthma Proc</MedlineTA><NlmUniqueID>9603640</NlmUniqueID><ISSNLinking>1088-5412</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A. L. Boner serves as a consultant for Envicon Medical srl Italy. The remaining author have no conflicts to declare</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>7</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35524358</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster - long-haul Covid. N Engl J Med. 2021; 385:577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ. 2021; 374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. . Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022; 39:159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. . Preliminary evidence on long COVID in children. Acta Paediatr. 2021; 110:2208&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021; 11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al. . The conundrum of 'long-COVID-19': a narrative review. Int J Gen Med. 2021; 14:2491&#x2013;2506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006; 333:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun Rev. 2018; 17:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and kids: more research is urgently needed. Nature. 2022; 602:183.</Citation><ArticleIdList><ArticleId IdType="pubmed">35136225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafilyan V, Islam N, Ayoubkhani D, et al. . Ethnicity, household composition and COVID-19 mortality: a national linked data study. J R Soc Med. 2021; 114:182&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994923</ArticleId><ArticleId IdType="pubmed">33759630</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Gennaro L, Rose C, et al. . Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid. Future Microbiol. 2022. Mar (in press).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021; S1198-743X(21)00629&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S, Sreenivasulu K, Mitra P, et al. . Role of genetic variants and gene expression in the susceptibility and severity of COVID-19. Ann Lab Med. 2021; 41:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7591285</ArticleId><ArticleId IdType="pubmed">33063674</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 GWAS Group, Ellinghaus D, Degenhardt F, et al. . Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020; 383:1522&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, et al. . Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front Immunol. 2022; 12:746021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X-H, He Z-C, Li T-Y, et al. . Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res. 2020; 30:541&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186763</ArticleId><ArticleId IdType="pubmed">32346074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienhold R, Ciani Y, Koelzer VH, et al. . Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun. 2020; 11:5086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546638</ArticleId><ArticleId IdType="pubmed">33033248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021; 53:737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D, Sojka M, Dobrodenkov&#xe1; S, et al. . SARS-CoV-2 RNA in the cerebrospinal fluid of a patient with long COVID. Ther Adv Infect Dis. 2021; 8:20499361211048572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020; 5:434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Omololu A, Ojelade B, Ajayi O, et al. . Long COVID&#x201d;: a case report of persistent symptoms in a patient with prolonged SARS-CoV-2 shedding for over 110 days. SAGE Open Med Case Rep. 2021; 9:2050313X211015494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132077</ArticleId><ArticleId IdType="pubmed">34035919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellanti JA, Green RE. Immunological reactivity. Expression of efficiency in elimination of foreignness. Lancet. 1971; 2:526&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">4105669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellanti JA. Immunology IV: Clinical Applications in Health and Disease. Bethesda, MD: I Care Press; 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22730565</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021; 13:700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, et al. . Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71:762&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021; 4:100100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter AG, Shields AM, Karim A, et al. . Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021; 205:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, et al. . Covid-19 and autoimmunity. Autoimmun Rev. 2020; 19:102597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagiannis D, Steinestel J, Hackenbroch C, et al. . Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Front Immunol. 2020; 11:587517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566417</ArticleId><ArticleId IdType="pubmed">33123171</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Han T, Chen J, et al. . Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020; 13:1077&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med. 2021; 27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020; 17:1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al. . Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostanc&#x131;kl&#x131;o&#x11f;lu M. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain. Brain Behav Immun. 2020; 87:122&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189839</ArticleId><ArticleId IdType="pubmed">32360606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh&#xf6;fer B, Frommer T, Haley G, et al. . TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006; 177:2088&#x2013;2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">16887967</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb K, Peckham H, Radziszewska A, et al. . Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration. Front Immunol. 2019; 9:3167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345344</ArticleId><ArticleId IdType="pubmed">30705679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Buonsenso D, Carfi A, et al. . Long COVID: an estrogen-associated autoimmune disease? Cell Death Discov. 2021; 7:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC-Y, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021; 70:698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157:121&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Tong T, Chew J, et al. . Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2020; 13:1361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971226</ArticleId><ArticleId IdType="pubmed">32009871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, et al. . Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021; 10:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Gao F. Clinical characteristics of primary and reactivated Epstein-Barr virus infection in children. J Med Virol. 2020; 92:3709&#x2013;3716.</Citation><ArticleIdList><ArticleId IdType="pubmed">32558948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. . Evolution of antibody immunity to SARS-CoV-2. Nature. 2021; 591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Tao W, Flavell RA, et al. . Potential intestinal infection and fecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021; 18:269&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883337</ArticleId><ArticleId IdType="pubmed">33589829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J, Anto JM, Czarlewski W, et al. . Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy. 2021; 76:735&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436771</ArticleId><ArticleId IdType="pubmed">32762135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A, Hui DS, Azhar EI, et al. . Reducing mortality from 2019-nCoV: host directed therapies should be an option. Lancet. 2020; 395:e35&#x2013;e36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133595</ArticleId><ArticleId IdType="pubmed">32035018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R, Schuster M, Planz O. COVID-19: mechanistic model of the African paradox supports the central role of the NF-&#x3ba;B pathway. Viruses. 2021; 13:1887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8473087</ArticleId><ArticleId IdType="pubmed">34578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang L, Joo D, et al. . NF-&#x3ba;B signaling in inflammation. Signal Transduct Target Ther. 2017; 2:17023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanan T, Kanan D, Al Shardoub EJ, et al. . Transcription factor NF-&#x3ba;B as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model. J Mol Graph Model. 2021; 108:107968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219481</ArticleId><ArticleId IdType="pubmed">34311260</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol. 2012; 4:a011254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536342</ArticleId><ArticleId IdType="pubmed">23125017</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Shi Y, Gong B, et al. . Dynamic blood single-cell immune responses in patients with COVID-19. Signal Transduct Target Ther. 2021; 6:110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936231</ArticleId><ArticleId IdType="pubmed">33677468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandasamy M. NF-&#x3ba;B signalling as a pharmacological target in COVID-19: potential roles for IKK&#x3b2; inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2021; 394:561&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780215</ArticleId><ArticleId IdType="pubmed">33394134</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigelius-Floh&#xe9; R, Floh&#xe9; L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal. 2011; 15:2335&#x2013;2381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3166203</ArticleId><ArticleId IdType="pubmed">21194351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>